ZD
Schedule 13G filing
Zedek Daniel Clayton disclosed a 5.4% stake in ACET
Zedek Daniel Clayton reported owning 5.4% of Adicet Bio, Inc. (ACET) (502,309 shares) in a Schedule 13G filed Oct 23, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.